We did not quantify Piezo1 expression or activation in the gut, but future studies may explore if the level of Piezo1 expression or activation may vary in different conditions or disease states, for example, in patients with obesity or binge-eating disorder. This evidence concerns the gene PIEZO1 and obesity due to melanocortin 4 receptor deficiency.